Elite Pharmaceuticals (ELTP) Return on Capital Employed [ROCE] (2011 - 2026)
Elite Pharmaceuticals (ELTP) reported Return on Capital Employed [ROCE] of 32.19% for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 8.02 percentage points from 40.21% a year earlier and down 10.53 percentage points from the prior quarter.
Powered by 
Analysis
Elite Pharmaceuticals (ELTP) Return on Capital Employed [ROCE] (2011 - 2026) Analysis & Trends
For FY2026 (ended Mar 31, 2026), Elite Pharmaceuticals posted Return on Capital Employed [ROCE] of 49.14%, up 24.07 percentage points from FY2025.
- Return on Capital Employed [ROCE] has increased for three consecutive fiscal years, with a five-year change of +38.49 percentage points (FY2021 to FY2026).
- By fiscal year, Return on Capital Employed [ROCE] came in at 25.07% in FY2025 (+3.15 pp), 21.92% in FY2024 (+9.74 pp), 12.18% in FY2023 (-8.97 pp) and 21.15% in FY2022 (+10.50 pp).
- The fiscal Q1 2027 figure ranks as the lowest quarterly Return on Capital Employed [ROCE] since fiscal Q4 2025.
- Year over year, Return on Capital Employed [ROCE] gained in seven of the last eight quarters, with an average year-over-year change of +12.73 percentage points.
- The high point for year-over-year Return on Capital Employed [ROCE] in five years was fiscal Q3 2026 (a gain of 29.82 percentage points); the low point was fiscal Q4 2023 (a drop of 9.45 percentage points).
- Per Business Quant data, the three fiscal quarters before Q1 2027 came in at 42.72% (Q4 2026), 46.10% (Q3 2026) and 40.69% (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 17.52% |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 16.76% |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 11.86% |
| 10 | Elite Pharmaceuticals | 269.28 Mn | 150.96 Mn | 13.51 Mn | 32.19% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 32.19% |
| Mar 31, 2026 | 42.72% |
| Dec 31, 2025 | 46.10% |
| Sep 30, 2025 | 40.69% |
| Jun 30, 2025 | 40.21% |
| Mar 31, 2025 | 23.98% |
| Dec 31, 2024 | 16.28% |
| Sep 30, 2024 | 19.44% |
| Jun 30, 2024 | 18.19% |
| Mar 31, 2024 | 16.32% |
| Dec 31, 2023 | 12.46% |
| Sep 30, 2023 | 12.90% |
| Jun 30, 2023 | 13.46% |
| Mar 31, 2023 | 9.43% |
| Dec 31, 2022 | 10.95% |
| Mar 31, 2022 | 18.88% |
| Dec 31, 2021 | 12.40% |
| Sep 30, 2021 | 9.67% |
| Jun 30, 2021 | 10.51% |
| Mar 31, 2021 | 9.74% |
API Access
Elite Pharmaceuticals Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ELTP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();